Skip to main content
31/08/2010

New expectations for the treatment of metabolic diseases

2010_0189_2010_0189_IMATGE

31/08/2010

Researchers from Vall d'Hebron Research Institute (VHIR) lead an unprecedented study that shows that it is possible to modify the composition of the intestinal flora transplanting it, and that generated changes remain, beyond expectations, up to three months after transplantation. The ability to validate treatments that can make changes in the composition of the flora would be a before and after in those diseases where there is scientific evidence that intestinal flora plays a determinant role. This research, published in the journal Genome Research, makes it possible to introduce new species in the normal intestinal flora just by taking and contends that it is not necessary to remove previously part of the existing flora with antibiotics as previously thought.

Researchers from Vall d'Hebron Research Institute (VHIR) lead an unprecedented study that shows that it is possible to modify the composition of the intestinal flora transplanting it, and that generated changes remain, beyond expectations, up to three months after transplantation. The ability to validate treatments that can make changes in the composition of the flora would be a before and after in those diseases where there is scientific evidence that intestinal flora plays a determinant role. This research, published in the journal Genome Research, makes it possible to introduce new species in the normal intestinal flora just by taking and contends that it is not necessary to remove previously part of the existing flora with antibiotics as previously thought.

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.